Furthermore, EMP3 suppressed T cell infiltration into GBM tumors by inhibiting the secretion of CXCL9 and CXCL10 by macrophages and led to an effective response to anti-PD1 therapy [48]. The gene discussed is CXCL10; the disease is glioblastoma.